Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study

AIM: Patients with severe mitral regurgitation (MR) and acute heart failure (HF) have refractory symptoms without adequate response to medical therapy. The objective of this analysis was to assess the impact of the MitraClip device in acutely ill HF patients, characterized by NYHA Class IV at baseli...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuvy, Mony, von Bardeleben, Ralph Stephan, Grasso, Carmelo, Raake, Philip, Lurz, Philipp, Zamorano, Jose L., Asch, Federico, Kar, Saibal, Maisano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053175/
https://www.ncbi.nlm.nih.gov/pubmed/36599332
http://dx.doi.org/10.1002/ehf2.14273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053175/
https://www.ncbi.nlm.nih.gov/pubmed/36599332
http://dx.doi.org/10.1002/ehf2.14273

Ejemplares similares